1. World Health Organization. Global tuberculosis control: WHO Report 2010. Geneva (Switzerland): World Health Organization;2011. p. 9–27.
2. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med. 2012; 367:348–61.
Article
3. Kim HJ. Current status of tuberculosis in Korea. Korean J Med. 2012; 82:257–62.
Article
4. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009; 33:956–73.
Article
5. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med. 2006; 173:1078–90.
6. Joint Committee for the Development of Korean Guidelines for Tuberculosis Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 2nd ed.Cheongju: Korea Centers for Disease Control and Prevention;2014. p. 143–5.
7. Riley RL, Moodie AS. Infectivity of patients with pulmonary tuberculosis in inner city homes. Am Rev Respir Dis. 1974; 110:810–2.
8. Wood R, Johnstone-Robertson S, Uys P, Hargrove J, Middelkoop K, Lawn SD, et al. Tuberculosis transmission to young children in a South African community: modeling household and community infection risks. Clin Infect Dis. 2010; 51:401–8.
Article
9. Gessner BD, Weiss NS, Nolan CM. Risk factors for pediatric tuberculosis infection and disease after household exposure to adult index cases in Alaska. J Pediatr. 1998; 132(3 Pt 1):509–13.
Article
10. Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet. 1999; 353:444–9.
Article
11. Nakaoka H, Lawson L, Squire SB, Coulter B, Ravn P, Brock I, et al. Risk for tuberculosis among children. Emerg Infect Dis. 2006; 12:1383–8.
Article
12. Joint Committee for the Development of Korean Guidelines for Tuberculosis Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. Cheongju: Korea Centers for Disease Control and Prevention;2011. p. 141–9.
13. Al-Marri MR, Kirkpatrick MB. Erythrocyte sedimentation rate in childhood tuberculosis: is it still worthwhile? Int J Tuberc Lung Dis. 2000; 4:237–9.
14. Furuhashi K, Shirai T, Suda T, Chida K. Inflammatory markers in active pulmonary tuberculosis: association with Th1/Th2 and Tc1/Tc2 balance. Kekkaku. 2012; 87:1–7.
15. Ali NS, Hussain SF, Azam SI. Is there a value of mantoux test and erythrocyte sedimentation rate in pre-employment screening of health care workers for tuberculosis in a high prevalence country? Int J Tuberc Lung Dis. 2002; 6:1012–6.
16. Walzl G, Ronacher K, Djoba Siawaya JF, Dockrell HM. Biomarkers for TB treatment response: challenges and future strategies. J Infect. 2008; 57:103–9.
Article
17. Lobue P, Menzies D. Treatment of latent tuberculosis infection: an update. Respirology. 2010; 15:603–22.
Article
18. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Nelson LJ, et al. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004; 8:278–85.